Preclinical evaluation of the urokinase receptor-derived peptide UPARANT as an anti-inflammatory drug

Boccella, Serena; Belardo, Carmela; de Novellis, Vito; PANZA, ELISABETTA; LISTA, LILIANA; IANARO, ANGELA; DE ROSA, MARIO; PAVONE, VINCENZO

research article

oai:www.iris.unina.it:11588/677607

Preclinical evaluation of the urokinase receptor-derived peptide UPARANT as an anti-inflammatory drug

Authors: Serena Boccella
Carmela Belardo
Vito de Novellis
ELISABETTA PANZA
LILIANA LISTA
ANGELA IANARO
MARIO DE ROSA
VINCENZO PAVONE
Publication date: 1 January 2017
Publisher
Doi

Abstract

Inflammation plays a key role in the pathogenesis of several chronic diseases. The urokinase plasminogen activator receptor (uPAR) exerts a plethora of functions in both physiological and pathological processes, including inflammation

Similar works

Full text

Archivio della ricerca - Università degli studi di Napoli Federico II

oai:www.iris.unina.it:11588/67...

Last time updated on 20/07/2017

This paper was published in Archivio della ricerca - Università degli studi di Napoli Federico II.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.